Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
18.59
+0.21 (1.14%)
Mar 10, 2026, 10:45 AM CST
SHE:002932 Market Cap
SHE:002932 has a market cap or net worth of 4.03 billion as of March 9, 2026. Its market cap has decreased by -2.11% in one year.
Market Cap
4.03B
Enterprise Value
460.40M
Revenue
351.25M
Ranking
n/a
PE Ratio
568.40
Stock Price
18.59
Market Cap Chart
Since July 10, 2018, SHE:002932's market cap has increased from 1.96B to 4.03B, an increase of 105.71%. That is a compound annual growth rate of 9.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.06B | -3.60% |
| Dec 31, 2025 | 4.21B | 2.60% |
| Dec 31, 2024 | 4.10B | -23.18% |
| Dec 29, 2023 | 5.34B | -40.29% |
| Dec 30, 2022 | 8.95B | 15.26% |
| Dec 31, 2021 | 7.76B | 78.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hangzhou AGS MedTech | 4.69B |
| Medprin Regenerative Medical Technologies | 4.60B |
| Zhejiang Orient Gene Biotech | 4.50B |
| Shanghai Kinetic Medical | 4.43B |
| Nanjing Medlander Medical Technology | 4.25B |
| Getein Biotech | 4.25B |
| Ningbo David Medical Device | 4.11B |
| Beijing Leadman Biochemistry | 3.74B |